MRC Centre for Outbreak Analysis & Modelling, Department of Infectious Disease Epidemiology, Imperial College London, UK; Division of Population Health & Immunity, Walter and Eliza Hall Institute, Melbourne, Australia.
Department of Parasites & Insect Vectors, Institut Pasteur, Paris, France.
Trends Parasitol. 2017 Apr;33(4):260-263. doi: 10.1016/j.pt.2016.12.011. Epub 2017 Jan 8.
Preventing malaria infection through vaccination requires preventing every sporozoite inoculated by mosquito bite: a major challenge for Plasmodium falciparum. Plasmodium vivax sporozoites consist of tachysporozoites causing primary infection and bradysporozoites leading to relapses. We hypothesise that a candidate P. vivax vaccine with low efficacy against primary infection may substantially reduce transmission by preventing relapses.
这是恶性疟原虫面临的主要挑战。间日疟原虫的子孢子包括引起初次感染的速发型子孢子和导致复发的缓发型子孢子。我们假设一种针对初次感染效果较低的候选间日疟原虫疫苗,可能通过预防复发而大幅减少传播。